-
2019 1
X
LTBI
()
()
1. 5
2. NAA
1
1
1.
2. 3.
10-1
1. TB
2.
3.
5
)
1.
2.
3.
/
1.
X
2.
-
()
3 1 1
1
() /X
()
1.
2. 1 8 40
3.
()
1 8 40
-
()
() 5
() 10-2
() 10-3-1 10-3-2
() >>
>>>>>
() 2
2
()()
TB
//
-
()
> > > >
>
() 10-4
10-5
2
2
()
LTBI
10-6
TB
/
TB
LTBI
-
()
10-7 3
1. 1 X 3 X
2. MTBC
MTBC 13 13()
13()(
)() LTBI
3. LTBI LTBI / LTBI
12 X
4. LTBI/
3
X
(TST) (IGRA)
LTBI
LTBI
5
LTBI
5
1
LTBI
12
1
TST
3
2
3
8
-
X
(TST) (IGRA)
TB
/
RR/MDRTB
48-72
HIV/TNF- inhibitor/
//
/
5mm
10mm
LTBI
LTBI
Mitogen-
Nil
-
/ 4
4/
//
//
1.
2.
/
/
1.
2.
1.
2.
1.
2.
3. LTBI
4.
1.
2.
3. LTBI
4.
/
-
5
5
1.
2. X
3. LTBI 3
HIV 3
LTBI
1. 30() TST
2. /LTBI
10-8
3. 5
DR-TB
RR/MDR/
XDR/TDR-TB
1. RR-TB/MDR-TB 1DR-
TB 3
X
2. 1 X
DR-TB 2 DR-TB
2 LTBI
3. MDR-TB TB
MDR-TB
TB
MDR-TB
4. MDR/XDR TB
MDR-TB
10-9
X DR-TB
2 DR-TB 2
-
1.
(1)
(2)
aerosol- generating procedures
(3)
2.
N95 ()
3.
/
4.
1.
2. /
/
/
1.
2. /
/
3. RR-/MDR-TB()
X 2
( 106 5 19 1060300559)
TB
X
LTBI
-
()
1. 3
2.
()
1064
1269
() 4
1.
2.
3.
4.
A>B>C(A)(A)
(B)(C)
C
B
A
ex: 20
ex: 30
40
3
-
4
() TB 10-10
() ) 10-11
() 10-1210-13
() 10-1410-15
() >>
>>
() 10-16
() 10-17
() 10-18
() 10-19
5 MDR/XDR
3
2
-
6
5 MDR/XDRTB
5
5
MDR
X
1. TB/MDR TB /XDR TB
2. TB/MDR TB
3. TB/MDR TB
* 10-210-3-110-3-2 10-9
Monitor: Alert
https://monitor.cdc.gov.tw/stoptb/Alert.aspx?funid=1
>PersonalView>
30
30 X
MTBC 5 1 3 TST
-
MTBC5 13 90 IGRA
MTBC 90 IGRA
10 12
1.
2.
3.
4.
//
1. //
2.
1. /
2.
3.
4. TB
5. LTBI
6.
